Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-HDS vs R-CHOP in High-Risk Follicular Lymphoma
NCT00435955Phase 3Unknown
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Mar 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by AOU Città della Salute e della Scienza di Torino. Status: unknown.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00435955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435955.